Brian Goff - Chief Executive Officer, Director at Agios Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
AGIO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Brian Goff - trading volume in the past year for Agios Pharmaceuticals, Inc.

Holdings reported by Brian Goff for Agios Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Performance share units 76.6K $3.4M $44.39 Jun 5, 2024 Direct Common stock
Common stock 78.8K $3.37M $42.75 Aug 8, 2024 Direct
Restricted stock units 22.7K $995K $43.85 Aug 8, 2024 Direct Common stock
Stock options (right to buy) 196K Mar 1, 2024 Direct Common stock

Transactions reported by Brian Goff for Agios Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.